# sulfadoxine/pyrimethamine = sp

### notes
+ prescription under medical supervision

### therapeutic action
+ antimalarial

### indications
+ treatment of uncomplicated falciparum malaria, in combination with artesunate
+ completion treatment following parenteral therapy for severe falciparum malaria, in combination with artesunate

### presentation
+ sulfadoxine 500 mg/pyrimethamine 25 mg co-formulated tablet

### dosage and duration
+ child and adult: 25 mg/kg sulfadoxine and 1.25 mg/kg pyrimethamine as a single dose

| age              | 2 months | 1 year  | 7 years | 13 years | adult |
|------------------|----------|---------|---------|----------|-------|
| 500/25 mg tablet    | -        | 1/2 tab | 1 tab   | 2 tab    | 3 tab |

### contra-indications, adverse effects, precautions
+ do not administer to patients with allergy to sulfonamides.
+ may cause: gastrointestinal disturbances; allergic reactions, sometimes severe (toxic epidermal necrolysis and stevens-johnson syndrome); anaemia, leukopenia, agranulocytosis, thrombocytopenia, haemolytic anaemia in patients with g6pd deficiency.
+ do not use in combination with cotrimoxazole.
+ do not give folic acid on the same day sp is administered, or within 15 days thereafter.
+ *pregnancy*: no contra-indication
+ *breast-feeding*: no contra-indication

### remarks
+ in stable transmission areas, intermittent preventive treatments can be given to pregnant women as of the 2nd trimester to reduce the consequences of malaria (anaemia, low birth weight, etc.). check national recommendations.
+ sp should not be used for malaria prophylaxis.
+ storage: below 25°c